I always felt they didn't have enough respect for the processes which the FDA follows. Poorly designed trials rather than failure of what their biotech. Most unfortunate for shareholders and also for their potential patient base.
- Forums
- ASX - Short Term Trading
- STTrading weekend thread 14th and 15th December 2024
STTrading weekend thread 14th and 15th December 2024, page-28
Featured News
Featured News
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online